IFO50363 KU812
Cell information
Cell type:general cells (View Pricing Information)
| JCRB No. | IFO50363 | Cell Name | KU812 |
|---|---|---|---|
| Profile | leukemia, chronic myeloid | Other Name | |
| Animal | human | Strain | |
| Genus | Homo | Species | sapiens |
| Sex | M | Age | |
| Identity | available | Tissue for Primary Cancer | hemo-lymphocytic |
| Case history | leukemic cell | Metastasis | |
| Tissue Metastasized | Genetics | ||
| Life Span | infinite | Crisis PDL | |
| Morphology | myeloblast-like | Character | leukemia, chronic myeloid |
| Classify | tumor | Established by | Kishi, K. |
| Registered by | Kishi,K. | Regulation for Distribution | |
| Comment | Year | 1991 | |
| Medium | RPMI1640 medium with 10% fetal bovine serum | Methods for Passages | dilution |
| Cell Number on Passage | Race | ||
| CO2 Conc. | 5 % | Tissue Sampling | peripheral blood |
| Tissue Type |
| Detection of virus genome fragment by Real-time PCR | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Detected DNA Virus | tested | Detected RNA Virus | tested | ||||||
| CMV | - | parvoB19 | - | HCV | - | HTLV-1 | - | ||
| EBV | - | HBV | - | HIV-1 | - | HTLV-2 | - | ||
| HHV6 | - | HTLV-1 | - | HIV-2 | - | HAV | - | ||
| HHV7 | - | HTLV-2 | - |
-/negative. +/positive. nt/not tested. (positive (+) does not immediately mean the production of infectious viral particles.) |
|||||
| BKV | - | HIV-1 | - | ||||||
| JCV | - | HIV-2 | - | ||||||
| ADV | - | HPV18 | - | ||||||
| Notes | |||||||||
| Reference | |
|---|---|
| Pubmed id:2436686 | A monoclonal antibody reacting with human basophils. Bodger MP,Mounsey GL,Nelson J,Fitzgerald PH Blood. 1987 May;69(5):1414-8 |
| Pubmed id:3695564 | Induction of differentiation of the human leukemia cell line, KU812. Fischkoff SA,Kishi K,Benjamin WR,Rossi RM,Hoessly MC,Hoxie JA,Seals C,Anderson L,Ishizaka T,Hakimi J Leuk Res. 1987;11(12):1105-13 |
| Pubmed id:3858609 | A new leukemia cell line with Philadelphia chromosome characterized as basophil precursors. Kishi K Leuk Res. 1985;9(3):381-90 |
| Images |
|---|
![]() ![]() |
LOT Information
Viability/Growth rate/Cell number are represented as actual values measured at lot presentation in JCRB, but are not guaranteed values. Additionally, the doubling time is a rough value measured during passages.| Cell No. | IFO50363 | Cell Name | |
|---|---|---|---|
| LOT No. | 07082010 | Lot Specification | distribution |
| Medium | RPMI1640 medium with 10% fetal bovine serum (GIBCO Cat. # 10099) | Temperature | 37 C |
| Cell Density at Seeding | 1.7 - 2.5 x 10^5 cells/mL | Methods for Passages | Simple dilution (suspension culture), split ratio 1:4 - 1:6. |
| Doubling Time | approx. 2 days | Cell Number in Vial (cells/1ml) | 3.5 x 10^6 |
| Viability at cell freezing (%) | 90.9 | Antibiotics Used | free |
| Passage Number | Unknown (6 at bank) | PDL | |
| Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
| Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD (type B), MD. |
| Chromosome Mode | Chromosome Information | ||
| Surface Antigen | DNA Profile (STR) | D5S818:10 D13S317:8 D7S820:12 D16S539:9 VWA:15 TH01:9 AM:X,Y TPOX:12 CSF1PO:12,13 |
|
| Adhesion | No | Exoteric Gene | |
| Medium for Freezing | 10% DMSO, 20% FBS - RPMI1640 | CO2 Conc. | 5% |
| Viability immediately after thawing (%) | Additional information |
| Cell No. | IFO50363 | Cell Name | KU812 |
|---|---|---|---|
| LOT No. | 972 | Lot Specification | distribution |
| Medium | RPMI 1640, 90% ; FBS, 10% | Temperature | 37 C |
| Cell Density at Seeding | Methods for Passages | dilution | |
| Doubling Time | Cell Number in Vial (cells/1ml) | 7 x 10^5 | |
| Viability at cell freezing (%) | 80 | Antibiotics Used | free |
| Passage Number | Unknown (9 at IFO) | PDL | |
| Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
| Sterility: FUNGI | - | Isozyme Analysis | NP, G6PD(type B), AST |
| Chromosome Mode | Chromosome Information | ||
| Surface Antigen | DNA Profile (STR) | ||
| Adhesion | Exoteric Gene | ||
| Medium for Freezing | 10% DMSO, 20% serum (final conc.) - culture medium | CO2 Conc. | |
| Viability immediately after thawing (%) | Additional information |

